How It Works

Tesamorelin binds to Growth Hormone Releasing Hormone (GHRH) receptors in the anterior pituitary gland, stimulating the natural release of growth hormone. The resulting increase in GH promotes hepatic production of IGF-1, supporting fat metabolism, tissue repair, protein synthesis, and lean muscle maintenance. Tesamorelin has demonstrated a particular affinity for reducing visceral abdominal fat, helping improve waist circumference and overall body composition while maintaining endogenous hormone regulation. Its physiological mechanism helps preserve the body's natural feedback system without directly replacing growth hormone.

Frequently Used For

Tesamorelin is commonly incorporated into professionally supervised protocols for:

• Reducing stubborn visceral abdominal fat
• Supporting lean body recomposition
• Preserving lean muscle mass during fat-loss phases
• Optimizing natural growth hormone and IGF-1 production
• Supporting recovery following intensive training
• Improving metabolic efficiency and fat utilization
• Enhancing physique during cutting and body recomposition programs
• Supporting healthy ageing and overall metabolic wellness

Dosage & Storage

Dosage should be individualized according to treatment goals and administered under the supervision of a qualified healthcare professional. Typical protocols utilize 300–600mcg once daily via subcutaneous injection, preferably before bedtime, for 8–12 weeks, depending on individual objectives and clinical guidance.

Store lyophilized vials at 2–8°C, protected from direct sunlight. After reconstitution, refrigerate immediately, avoid freezing, and maintain proper aseptic handling throughout preparation and administration.

Possible Side Effects

Tesamorelin is generally well tolerated when used appropriately. Some individuals may experience injection-site reactions, mild fluid retention, headache, joint discomfort, muscle aches, nausea, or temporary increases in blood glucose levels. If severe or persistent adverse effects occur, discontinue use and consult a healthcare professional.

Precautions

Tesamorelin should only be used under professional medical supervision. Individuals with diabetes or impaired glucose tolerance should monitor blood glucose regularly throughout treatment. Avoid use in individuals with active malignancy, pituitary disorders, or hypersensitivity to Tesamorelin or its components. Pregnant or breastfeeding individuals should not use this product. Regular monitoring of IGF-1 levels and metabolic health may be recommended during therapy.

Stacking Compatibility

Tesamorelin is commonly incorporated into body recomposition, fat-loss, and performance-support protocols. It may be combined with medically supervised growth hormone secretagogues, metabolic-support peptides, or recovery-focused compounds to complement physique and performance goals. Any combination protocol should be individualized according to body composition objectives, metabolic status, and professional medical guidance.